PAR vs VIT

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

PAR

PARA BIO FPO [PAR]

48LOW

VIT

VITURA FPO [VIT]

49LOW

Score Breakdown

PAR VIT
Technical
53
53
Catalyst
51
51
Sentiment
50
50
Fundamental
60
76
Momentum
42
28
Risk Gate
50
45

Key Metrics

PAR Metric VIT
$99.4MMarket Cap$18.6M
2.2MAvg Volume (20d)682K
N/AShort InterestN/A
$0.47052-Week High$0.075
$0.13552-Week Low$0.021
-7.4%Daily Change+3.6%
$0.162Reference Price$0.029
-180.2%ROE+1.2%
N/AProfit Margin+0.6%

Active Signals

PAR Signals

●RSI drifting toward oversold territory — worth watching
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Drifting lower — down 4.7% over the last 5 days
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Very high P/S ratio (11766.1x)
●Strong revenue growth (+51%)

VIT Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.1x)
●Moderate revenue growth (+8%)
●Near 52-week low (13% of range)
●Micro-cap ($5-20M) - high risk

Ask Scout AI to compare PAR and VIT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

PCK vs RCE →PEB vs PKY →PEB vs RHY →PEB vs SLD →PGC vs RAC →
PAR Full Analysis → VIT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).